Skip to content
Medical Health Aged Care, Science

Can stem cells make drugs to stop osteoarthritis? Stomach stem cells behaving badly

National Stem Cell Foundation of Australia 2 mins read
The winners of the 2023 Metcalf Prizes for Stem Cell Research: Dr Jiao Jiao Li and Dr Dustin Flanagan

 

Can stem cells make drugs to stop osteoarthritis? (Sydney)

Stomach stem cells behaving badly (Melbourne)

Wednesday 15 November 2023

National Stem Cell Foundation of Australia’s Metcalf Prizes awarded today

Scientists available for interviews, see below for contact details
Profiles and photos available: www.scienceinpublic.com.au/stemcells

Researchers working with stem cells to find treatments for osteoarthritis and stomach cancer are the two winners of the 2023 Metcalf Prizes for Stem Cell Research, awarded by the National Stem Cell Foundation of Australia.

The Prizes will be presented today at the Australasian Society of Stem Cell Research Annual Scientific Meeting in Sydney.

Can stem cells make drugs to stop osteoarthritis?

Dr Jiao Jiao Li plans to use stem cells as biofactories to make drugs to reduce inflammation and encourage repair in painful osteoarthritic joints.

Osteoarthritis is a hugely debilitating joint disease with few treatment options.  Injecting stem cells to repair damaged joints has shown inconsistent and poor long-term results and the potential for adverse side effects.

“I believe it would be safer and more effective to use stem cells to create healing biomolecules and inject those instead,” says Jiao Jiao, a bioengineer at University of Technology Sydney.

Her $60,000 Metcalf Prize will contribute to her work across disciplines, using artificial intelligence, bioengineering, nanotechnology and stem cell science to develop new stem cell-derived treatments – initially for osteoarthritis but potentially for a wide range of other diseases.

Stomach stem cells behaving badly

People diagnosed with late-stage stomach cancer have a less than 10 per cent chance of surviving more than 5 years.

Dr Dustin Flanagan wants to boost that survival rate by understanding why some deviant stomach stem cells turn cancerous. This knowledge will help in the development of drugs to bring these misbehaving cells back to normal, healthy function.

Dustin’s past research has led to the development of treatments for Crohn’s disease, bowel cancer, and other gastrointestinal conditions.

He’s now at Monash Biomedicine Discovery Institute turning his attention to stomach cancer, which is less common than bowel cancer but just as lethal.

“Our goal is to make discoveries that have the potential to generate new therapies for therapy-resistant metastatic gastric cancer,” he says.

“These two remarkable researchers are revealing how the behaviour of different stem cells might cause or cure different diseases,” says Dr Graeme Blackman AO, the chairman of the Foundation.

The awards are named for the late Professor Donald Metcalf AC who, over a 50-year career, helped transform cancer treatment and transplantation medicine, paving the way for potential stem cell therapy in the treatment of many other conditions.

###

To arrange interviews, contact:

Tanya Ha, Science in Public, 0404 083 863, tanya@scienceinpublic.com.au

Niall Byrne, Science in Public, 0417 131 977, niall@scienceinpublic.com.au

About the National Stem Cell Foundation of Australia

The NSCFA is an ATO-registered, tax-deductible health promotion charity dedicated to promoting the study and responsible use of stem cells to reduce the burden of disease.

The Foundation’s activities include:

  • supporting research that pursues cures for as-yet-untreatable diseases;
  • building a community of people with a shared interest in stem cell science; and
  • providing the Australian public with objective, reliable information on both the potential and risks of stem cell medicine.

The Foundation is led by an expert volunteer Board, with a diversity of scientific, medical and governance experience. The Chairman is Dr Graeme Blackman, AO, FTSE, FAICD.

The Board consults with leading stem cell scientists before committing funds to research and education initiatives. More at: www.stemcellfoundation.net.au

Media

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 01/03/2024
  • 16:07
Leukaemia Foundation / World's Greatest Shave

Barry Du Bois loses his luscious locks for a cause that’s in his blood!

Barry Du Bois has today shaved off his locks in a nod to his own journey with the blood cancer myeloma, for the Leukaemia…

  • Contains:
  • Medical Health Aged Care
  • 01/03/2024
  • 14:00
Australian Nursing and Midwifery Federation (ANMF)

ANMF Statement: Vale Linda White

The country’s largest union, the Australian Nursing and Midwifery Federation (ANMF), has been deeply saddened by the tragic death of our dear friend and Comrade, Senator Linda White. As a former Assistant Secretary of the Australian Services Union (ASU) , Linda was long-recognised for her support of working women in this country. She fiercely advocated for the implementation of paid family and domestic leave, better retirement outcomes for women and helped secure strong affirmative action targets in the ALP. Linda fought and won equal pay for 200,000 community and social services workers, securing pay rises of up to 43% for…

  • Medical Health Aged Care
  • 01/03/2024
  • 13:23
Phebra Group

Phebra Group establishes new subsidiary pharma company: ‘Phero Pharma’ will fill medical shortages in the Australian health system

Leading Australian pharmaceutical firm Phebra Group (‘Phebra’) is delighted to announce the establishment of a new subsidiary, Phero Pharma Pty Ltd (‘Phero Pharma’). Phero will focus on identifying opportunities for in-licensing of products to address pharmaceutical needs across the Australian healthcare system. “The Phebra Group is very excited about the creation of this company, Phero Pharma,” Phebra Chief Executive Officer, Andre Vlok, said today. “As an Australian-based manufacturer, Phebra has been operating in Australia for over 30 years, working closely with clinicians, hospitals, and research facilities to develop niche products, including a range of critical medicines. “Australia has long been…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.